What is NDC 0409-1105?

0409-1105 is the product NDC for Atracurium Besylate, Atracurium besylate 10 mg/mL injection, solution, listed with the FDA by Hospira, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Hospira, Inc., NDC labeler code 0409. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Atracurium Besylate?

5 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Atracurium Besylate NDC 0409-1105 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0409-1105Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00409-1105Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0409-1105-02	00409110502	10 VIAL, MULTI-DOSE in 1 CARTON (0409-1105-02) / 10 mL in 1 VIAL, MULTI-DOSE (0409-1105-22)Marketed from May 29, 2013

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Atracurium Besylate
Generic name (nonproprietary): atracurium besylate
Active ingredients: Atracurium besylate — 10 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Hospira, Inc.NDC labeler code 0409
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090761
Marketing start: May 29, 2013
Listing expires: Dec 31, 2026
Other FDA classes: Neuromuscular Nondepolarizing Blockade (Physiologic effect)
Identifiers: Product ID 0409-1105_926d60c7-8585-42f2-a9fc-02fcb51dc2aeSPL ID 926d60c7-8585-42f2-a9fc-02fcb51dc2aeSPL set ID de1c2dcd-295b-47ce-b7a1-a8be59939a54RxCUI 966768, 1718913UNII 40AX66P76P
Pharmacologic class: Nondepolarizing Neuromuscular Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400409110502 followed by a unit qualifier and the quantity

Package 00409-1105-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 23, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Atracurium besylate injection is indicated, as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0409-1105

What is NDC 0409-1105?: 0409-1105 is the product NDC for Atracurium Besylate, Atracurium besylate 10 mg/mL injection, solution, listed with the FDA by Hospira, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Atracurium Besylate.
What is the active ingredient?: Atracurium besylate.
Who is the labeler?: Hospira, Inc., NDC labeler code 0409. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Atracurium Besylate?: 5 other product NDCs are listed under this name. See all Atracurium Besylate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Atracurium Besylate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Atracurium Besylate	Atracurium besylate 10 mg/mL	Injection, SolutionIntravenous	Meitheal Pharmaceuticals Inc.	71288-701	71288-0701-05
Atracurium Besylate	Atracurium besylate 10 mg/mL	Injection, SolutionIntravenous	Meitheal Pharmaceuticals Inc.	71288-702	71288-0702-10
Atracurium Besylate	Atracurium besylate 50 mg/5mL	Injection, SolutionIntravenous	AuroMedics Pharma LLC	55150-216	55150-0216-05
Atracurium Besylate	Atracurium besylate 100 mg/10mL	Injection, SolutionIntravenous	AuroMedics Pharma LLC	55150-217	55150-0217-10
Atracurium Besylate	Atracurium besylate 10 mg/mL	Injection, SolutionIntravenous	Hospira, Inc.	0409-1109	00409-1109-01